Soini, E., Asseburg, C., Taiha, M., Puolakka, K., Purcaru, O., & Luosujärvi, R. (2017). Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland. Adv Ther.
Παραπομπή Chicago StyleSoini, Erkki, Christian Asseburg, Maarit Taiha, Kari Puolakka, Oana Purcaru, και Riitta Luosujärvi. "Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients With Moderate-to-Severe Rheumatoid Arthritis in Finland." Adv Ther 2017.
Παραπομπή MLASoini, Erkki, et al. "Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients With Moderate-to-Severe Rheumatoid Arthritis in Finland." Adv Ther 2017.